RIGL logo

RIGL
Rigel Pharmaceuticals

12,461
Mkt Cap
$475.13M
Volume
208,948.00
52W High
$52.24
52W Low
$15.50
PE Ratio
1.43
RIGL Fundamentals
Price
$27.04
Prev Close
$25.72
Open
$26.27
50D MA
$31.98
Beta
1.33
Avg. Volume
290,779.77
EPS (Annual)
$19.48
P/B
1.26
Rev/Employee
$1.69M
$705.27
Loading...
Loading...
News
all
press releases
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology Rigel Announces Publication of Final ARROW...
PR Newswire·18h ago
News Placeholder
More News
News Placeholder
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendat...
MarketBeat·3d ago
News Placeholder
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Madrigal (MDGL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·5d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Lowered to "Hold" at Wall Street Zen
Wall Street Zen cut Rigel Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·18d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Down - What's Next?
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Down - Time to Sell...
MarketBeat·28d ago
News Placeholder
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have been assigned a consensus rating of "Hold" from the seven research firms that are covering the company, Marketbeat Ratings...
MarketBeat·28d ago
News Placeholder
Rigel Pharmaceuticals Q4 Earnings Call Highlights
Rigel Pharmaceuticals (NASDAQ:RIGL) detailed record commercial performance for the fourth quarter and full year 2025, while outlining plans to pursue additional in-licensing opportunities and advance...
MarketBeat·28d ago
News Placeholder
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
Rigel (RIGL) delivered earnings and revenue surprises of -14.29% and 0.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·28d ago
News Placeholder
Earnings Summary: Rigel Pharmaceuticals Q4
read more...
Benzinga·28d ago
News Placeholder
Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings Results
Rigel Pharmaceuticals (NASDAQ:RIGL - Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported $13.54 earnings per share (EPS) for the quarter, beating...
MarketBeat·28d ago
<
1
2
...
>

Latest RIGL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.